Hypothesis

The p62:NBR1 ratio functions as a ubiquitin‑code rheostat that dictates which cellular components are spared during selective autophagy in transient OSKM‑mediated reprogramming. When the ratio favors p62, K63‑linked ubiquitin chains on damaged mitochondria and aggregates are preferentially captured; when NBR1 dominates, filament termination shields K48‑linked ubiquitin on lineage‑specifying transcription factors and active chromatin, preserving cellular identity while allowing epigenetic age reversal.

Mechanistic Basis

• p62 polymerizes via its PB1 domain into filaments that bind ubiquitinated cargo through its UBA domain, showing higher affinity for K63‑linked chains prevalent on oxidized mitochondria and protein aggregates [2].
• NBR1 contains a PB1 domain that caps p62 filaments and a UBA domain with shifted selectivity toward K48‑linked ubiquitin, which marks stable complexes including certain transcription factors [3].
• The relative concentration of p62 and NBR1 therefore sets a threshold: high p62 drives aggressive clearance of damage; high NBR1 limits filament growth, protecting K48‑marked complexes from engulfment.
• During partial reprogramming, transient OSKM suppresses mTORC1, activating AMPK, which phosphorylates p62 at Ser403 and NBR1 at Ser205, modulating their ubiquitin‑binding preferences and filament dynamics [1].

Testable Predictions

1. Ratio manipulation alters cargo selectivity – CRISPRi‑mediated knockdown of p62 or overexpression of NBR1 in human fibroblasts undergoing a single 4‑day OSKM pulse will shift the ubiquitin‑chain profile of autophagocytosed cargo, detectable by ubiquitin‑chain‑specific immunoprecipitation followed by mass spectrometry.
2. Lineage‑factor preservation correlates with NBR1 elevation – Conditions that increase the NBR1:p62 ratio will retain higher levels of fibroblast‑specific transcription factors (e.g., PRRX1, TWIST1) bound to H3K27ac‑marked enhancers, measured by ChIP‑seq and CUT&RUN, whereas p62‑biased conditions will show depletion of these factors.
3. Epigenetic age reversal requires balanced ratio – Only interventions that maintain a physiological p62:NBR1 ratio (approximately 1.5:1 in young cells) will produce a significant reduction in DNAmAge (Horvath clock) without loss of colony‑forming efficiency or pluripotency‑marker expression. Deviations in either direction will either fail to lower epigenetic age or cause dedifferentiation/apoptosis.
4. Phospho‑mutants break the rheostat – Expression of non‑phosphorylatable p62 (S403A) or NBR1 (S205A) will abolish the shift in ubiquitin‑chain preference seen after OSKM treatment, leading to indiscriminate autophagy and impaired rejuvenation, confirming kinase‑dependent tuning of the rheostat.

Experimental Outline

• Generate doxycycline‑inducible OSKM fibroblasts with CRISPRi sgRNAs targeting p62 or NBR1, and rescue constructs expressing wild‑type or phospho‑mutant versions.
• Treat cells with a 4‑day OSKM pulse, harvest at 0, 24, 48, and 72 h post‑withdrawal.
• Perform ubiquitin‑chain enrichment (using TUBE2 for K63, TUBE1 for K48) followed by LC‑MS/MS to quantify cargo specificity.
• Assess transcription factor occupancy at enhancers via CUT&RUN for H3K27ac and factor‑specific antibodies.
• Measure epigenetic age using the Horvath microarray clock and functional assays (senescence‑β‑gal, colony formation).

Potential Outcomes and Falsifiability

If the data show that altering the p62:NBR1 ratio does not change the ubiquitin‑chain selectivity of autophagy, or that lineage‑factor preservation and epigenetic age reset occur independently of this ratio, the hypothesis is falsified. Conversely, a consistent link between ratio‑dependent ubiquitin‑code readout, selective sparing of identity‑defining factors, and measurable age reversal would support the model and suggest that therapeutic modulation of this rheostat could enhance rejuvenation protocols while safeguarding cellular identity.